Nutrition and the gastrointestinal tract by Forbes, Alastair & Correia, M. Isabel T.D.
CE: P.P.; MCO/180515; Total nos of Pages: 2;
MCO 180515
AQ1
AQ3
EDITORIAL CURRENTOPINION Nutrition and the gastrointestinal tract1363-1950 Copyright  2015 WolteAlastair Forbes and Isabel CorreiaAQ4In this year’s issue, we again have a high-calibre
collection of topical reviews. Gracie and Ford (pp.
xxx–xxx) commence with an assessment of the role
of symbiotics (i.e. probiotics and prebiotics given
together) in patients with irritable bowel syndrome.
They first review the many randomized trials of
probiotics and the significant and persistent
reductions in symptoms that (on balance) these
yield – that may persist after the end of treatment.
Pain, bloating and flatulence are all better than with
placebo with a range of different regimens. How-
ever, although symbiotics appear promising, their
current conclusion is that the evidence for superi-
ority over probiotics alone is lacking.
Jin and Vos (pp. xxx–xxx) then consider the
pathophysiology of nonalcoholic fatty liver disease
and specifically the role of fructose. Their synthesis
of the literature includes the conclusion that
unregulated lipogenesis is key to nonalcoholic fatty
liver disease, linked to generalized increases in vis-
ceral adiposity – in turn probably secondary to
changes in the intestinal microbiota. Dietary fruc-
tose seems an important determinant of these
phenomena, and early-in-life exposure appears of
most significance. Although dogmatic advice is not
justified, continuing to argue for limitation of
dietary fructose seems wise.
Barrett et al. (pp. xxx–xxx) consider the immune
response in patients on artificial nutrition in the
current context wherein we aim for enteral nutri-
tion whenever possible – thus recognizing that
patients who need parenteral nutrition are then
an especially high-risk group. They conclude from
awide consideration of animal and human data that
the intestinal epithelial barrier is significantly com-
promised and to a clinically relevant extent in
patients on exclusive parenteral nutrition. They
encourage targeted new work to exploit theAQ2
rs Kluwer Health, Inc. All rights resemechanisms that have now been unearthed, such
that future parenteral nutrition could be used with
fewer adverse immunological consequences.
Plank and Russell (pp. xxx–xxx) look at nutri-
tion in liver transplantation incorporating new data
frompatients with concomitantmorbid obesity. It is
of course clear that obesity is a perioperative risk
factor but we lack proof that pretransplant weight
loss would change this. The main issue here is
probably the sarcopenic element, and weight loss
without muscle preservation (or growth) would be
unlikely to help. As obese patients are being trans-
planted, better data are clearly needed to guide
optimal nutritional strategies.
After a comprehensive review on the state of the
art on gluten sensitivity in the absence of coeliac
disease by David Sanders (pp. xxx–xxx), the issue
finishes with a intriguing article by Murphy et al.
(pp. xxx–xxx) in which they consider the evidence
that chronic disease is made more likely by changes
in the gut microbiota driven by a high-fat diet.
Although dysbiosis is present and linked to obesity,
on present evidence, this falls short of a direct
causal relationship.
We feel confident that readers will find plenty to
provoke thought and hopefully to stimulate
research in the many loci where data are sparse
or inconclusive.
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